Sphera Funds Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-397,177
| Closed | -$314K | – | 106 |
|
|
2025
Q1 | $314K | Hold |
397,177
| – | – | 0.07% | 106 |
|
|
2024
Q4 | $655K | Buy |
+397,177
| New | +$655K | 0.12% | 95 |
|
|
2022
Q2 | – | Sell |
-89,425
| Closed | -$3.47M | – | 57 |
|
|
2022
Q1 | $3.47M | Sell |
89,425
-96,051
| -52% | -$3.72M | 0.49% | 39 |
|
|
2021
Q4 | $10.9M | Sell |
185,476
-33,823
| -15% | -$1.98M | 1.19% | 25 |
|
|
2021
Q3 | $13M | Buy |
219,299
+54,000
| +33% | +$3.2M | 1.09% | 17 |
|
|
2021
Q2 | $14.3M | Buy |
165,299
+55,492
| +51% | +$4.82M | 0.97% | 17 |
|
|
2021
Q1 | $9.05M | Buy |
109,807
+27,807
| +34% | +$2.29M | 0.69% | 26 |
|
|
2020
Q4 | $7.46M | Sell |
82,000
-106,000
| -56% | -$9.64M | 0.66% | 43 |
|
|
2020
Q3 | $7.51M | Sell |
188,000
-37,000
| -16% | -$1.48M | 0.74% | 34 |
|
|
2020
Q2 | $7.72M | Buy |
+225,000
| New | +$7.72M | 0.73% | 32 |
|